INDUCTION OF RETINOID RESISTANCE BY ALL-TRANS-RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA AFTER REMISSION

被引：16

作者：

CORNIC, M

CHOMIENNE, C

机构：

[1] Laboratoire de: Biologie Cellulaire Hématopoiétique, Institut d'Hematologie Hôpital, Saint-Louis 75010, Paris

来源：

LEUKEMIA & LYMPHOMA | 1995年 / 18卷 / 3-4期

关键词：

RETINOID RESISTANCE; ALL-TRANS RETINOIC ACID; ACUTE PROMYELOCYTIC LEUKEMIA; APL; REMISSION;

D O I：

10.3109/10428199509059615

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Acute promyelocytic leukemia (APL) results from a malignant process that leads to the accumulation in the blood and the bone marrow of myeloid precursor cells characterized by an abnormal behavior and a differentiation arrest. It aroused considerable interest well beyond the hematologic field during the last five years since APL has two unique features i) the remission of the disease obtained with all-trans retinoic acid (ATRA) treatment ii) the presence in APL blasts of an abnormal protein, the promyelocytic myeloid leukemia/retinoic acid receptor (PML/RAR alpha) protein, APL is characterized cytogenetically by a t(15;17) translocation which involves both the PML gene on chromosome 15 and the RAR alpha gene on chromosome 17 and gives rise to the PML/RAR alpha fusion protein.

引用

页码：249 / 257

页数：9

共 114 条

[41]

Chen Z.X., Xue Y.Q., Zhang R., Tao R.F., Xia X.M., Li C., Wang W., Zu W.Y., Yao X.Z., Ling B.J., A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients, Blood, 78, pp. 1413-1419, (1991)

[42]

Frankel S.R., Eardley A., Lauwers G., Weiss M., Warrell R.P., The “retinoic acid syndrom” in acute promyelocytic leukemia, Ann. Intern. Med., 117, pp. 292-296, (1992)

[43]

Davies P.I.A., Murtaugh M.P., Moore W.T., Johnson G.S., Lucas D., Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia HL-60 cells, J. Biol. Chem., 260, pp. 5166-5174, (1985)

[44]

Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., Sultan C., Proposals for the classification of acute leukemia, Br. J. Haematol., 33, pp. 445-451, (1976)

[45]

Cordonnier C., Dreyfus F., Cassasus P., Leblond V., Pesce A., Teillet-Thibault F., Colombat P., Troussard X., Dombret H., Gouault M., Jouault H., Kuentz M., Karianakis G., Vemant J.P., Progressive induction for prevention of disseminated intravascular coagulation in acute promyelocytic leukemia: preliminary results, Infection and hemorrhage in acute leukemia, pp. 81-87, (1989)

[46]

Borrow J., Goddard A.D., Gibbons B., Kartz F., Swirsky D., Fioreto T., Dube I., Winfield D.A., Kingston J., Hagemeijer A., Rees J.K.L., Lister T.A., Solomon E., Diagnosis of acute promyelocytic leukaemia by RT-PCR detection of PMLRARα and RARαPML fusion transcript, Br. J. Haematol., 82, pp. 529-534, (1992)

[47]

Cunningham I., Gee T.S., Reich L., Kempin S.J., Naval A.N., Clarkson B.D., Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital, Blood, 73, pp. 1116-1122, (1989)

[48]

Kantarjian H.M., Keating M.J., Walters R.S., Acute promyelocytic leukemia: MDS Anderson Hospital experience, Am. J. Med., 80, pp. 789-797, (1986)

[49]

Thomas X., Archimbaud E., Treille-Ritouet D., Fiere D., Prognostic factors in acute promyelocytic leukemia: a retropective study of 67 cases, Leukemia Lymphoma, 4, pp. 249-256, (1991)

[50]

Rodeghiero F., Avvisati G., Castaman G., Barbui T., Mandelli F., Early death and anti-hemorrhagic treatment in acute promyelocytic leukemia. A Gimena study on 268 patients, Blood, 75, pp. 2111-2112, (1990)

← 1 2 3 4 5 6 7 8 9 10 →